MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner

by Felix Y. Feng, Yu Zhang, Vishal Kothari, Joseph R. Evans, William C. Jackson, Wei Chen, Skyler B. Johnson, Connor Luczak, Shaomeng Wang, Daniel A. Hamstra
Published 2016-04-01

Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes

by Neil K. Jairath, Mark W. Farha, Sudharsan Srinivasan, Ruple Jairath, Michael D. Green, Robert T. Dess, William C. Jackson, Adam B. Weiner, Edward M. Schaeffer, Shuang G. Zhao, Felix Y. Feng, Issam El Naqa, Daniel E. Spratt
Published 2020-06-01

Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19

by Nicholas G. Zaorsky, MD, James B. Yu, MD, Sean M. McBride, MD, Robert T. Dess, MD, William C. Jackson, MD, Brandon A. Mahal, MD, Ronald Chen, MD, Ananya Choudhury, MD, Ann Henry, MD, Isabel Syndikus, MD, Timur Mitin, MD, Alison Tree, MD, Amar U. Kishan, MD, Daniel E. Spratt, MD
Published 2020-11-01

Incorporating big data into treatment plan evaluation: Development of statistical DVH metrics and visualization dashboards

by Charles S. Mayo, PhD, John Yao, PhD, Avraham Eisbruch, MD, James M. Balter, PhD, Dale W. Litzenberg, PhD, Martha M. Matuszak, PhD, Marc L. Kessler, PhD, Grant Weyburn, BS, Carlos J. Anderson, PhD, Dawn Owen, MD, William C. Jackson, MD, Randall Ten Haken, PhD
Published 2017-07-01

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy

by William C. Jackson, MD, Felix Y. Feng, MD, Stephanie Daignault, PhD, Maha Hussain, MD, David Smith, MD, Kathleen Cooney, MD, Kenneth Pienta, MD, Shruti Jolly, MD, Brent Hollenbeck, MD, Karin B. Olson, PA-C, Howard M. Sandler, MD, Michael E. Ray, MD, PhD, Daniel A. Hamstra, MD, PhD
Published 2016-01-01